SAMARIUM-153, Sm-153

Indication: Used in oncology with the aim of a persistent reduction in the intensity of the pain syndrome, caused by the presence of metastatic damage bones and for rheumatic patients with severe pain syndrome. Also Sm-153 is very effective in the diagnosis and treatment of prostate and breast cancer.

Typical specification of Sm-153
Half-value period46,27 hours
Radionuclide puritynot less than 99,99%
Activitynot less than 240 MBq/ml